VEGFA and neoplasm: During experiments aimed at identifying drug combinations that exhibit beneficial effects in blocking tumour growth in MDAMB231 cell xenografts in mice, we found that the combination of the VEGF drug Bevacizumab with an Hsp90 inhibitor gave striking results.